Celldex Therapeutics is an antibody-based combination immunotherapy company with a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy (PTI) Platform. Celldex’ PTI Platform is comprised of monoclonal antibodies, antibody-targeted vaccines, and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information visit the company’s Web site at www.celldextherapeutics.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: